Accessibility Menu
 
Omeros logo

Omeros

(NASDAQ) OMER

Current Price$10.44
Market Cap$740.20M
Since IPO (2009)+17%
5 Year-46%
1 Year+14%
1 Month-9%

Omeros Financials at a Glance

Market Cap

$740.20M

Revenue (TTM)

$0.00

Net Income (TTM)

$121.16M

EPS (TTM)

$-2.02

P/E Ratio

-5.17

Dividend

$0.00

Beta (Volatility)

1.41 (Average)

Price

$10.44

Volume

60

Open

$10.39

Previous Close

$10.44

Daily Range

$10.30 - $10.70

52-Week Range

$2.95 - $17.65

OMER: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Omeros

Industry

Pharmaceuticals

Employees

202

CEO

Gregory A. Demopulos, MD

Headquarters

Seattle, WA 98119, US

OMER Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-65%

Earnings Yield

-19.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$740.20M

Shares Outstanding

70.90M

Volume

60

Short Interest

0.00%

Avg. Volume

1.73M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$169.26M

EBITDA

$157.00M

Operating Cash Flow

$148.80M

Capital Expenditure

$165.00K

Free Cash Flow

$148.97M

Cash & ST Invst.

$90.13M

Total Debt

$207.02M

Omeros Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$740.20M

N/A

Market Cap/Employee

$3.66M

N/A

Employees

202

N/A

Net Income

$30.92M

+4.1%

EBITDA

$15.59M

+52.5%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$155.52M

-80.2%

Accounts Receivable

$31.96M

-10.3%

Inventory

$0.00

N/A

Long Term Debt

$168.40M

-17.3%

Short Term Debt

$23.21M

+302.3%

Return on Assets

-65.24%

N/A

Return on Invested Capital

-1.23%

N/A

Free Cash Flow

$18.48M

+42.3%

Operating Cash Flow

$18.47M

+42.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LXRXLexicon Pharmaceuticals, Inc.
$1.68+0.60%
KALVKalVista Pharmaceuticals, Inc.
$16.61-3.09%
OCGNOcugen, Inc.
$1.92-1.54%
RAPTRAPT Therapeutics, Inc.
$58.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$44.39+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.18+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$76.96-0.02%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$16.41+0.03%

Questions About OMER

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.